Perseus Soros Biopharmaceutical Fund LP

Perseus Soros Biopharmaceutical Fund LP discloses dealings in 3 companies, chiefly MAP Pharmaceuticals, Inc., Bioenvision Inc and Auxilium Pharmaceuticals Inc. Over a trading history stretching from 5 December 2006 to 11 May 2010, the count stands at 10 filings.

The open-market side counts 1 purchase for €1.5M alongside 1 sale for €18.0M. Taken together, the sales exceed the purchases by €16.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant.

The newest entry dates from 13 May 2010: a transaction, in MAP Pharmaceuticals, Inc. The last purchase on record was published on 12 October 2007, which is 6,951 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.